BioLineRx LtdGewinn- und Verlustrechnung
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 2.8200000000000003 USD | 4,56 USD | 2,15 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 17,5 USD | 1 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 4.351.357 | 3,36 | 5,84 |
Kennzahl in 1000 USD | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - |
Herstellungskosten | - | - | - | - | - | - | - | - |
Bruttoergebnis | - | - | - | - | - | - | - | - |
▸ Brutto-Marge | -% | -% | -% | -% | -% | -% | -% | -% |
Betriebliche Aufwendungen | - | - | - | - | - | - | - | - |
Operativer Gewinn/Verlust | - | - | - | - | - | - | - | - |
▸ Operative Marge | -% | -% | -% | -% | -% | -% | -% | -% |
Zinsen (Netto) | - | - | - | - | - | - | - | - |
▸ Zinsausgaben | - | - | - | - | - | - | - | - |
▸ Zinseinnahmen | - | - | - | - | - | - | - | - |
Andere Ausgaben | - | - | - | - | - | - | - | - |
Gewinn vor Steuern | - | - | - | - | - | - | - | - |
Steueraufwand | - | - | - | - | - | - | - | - |
Minderheitenanteil | - | - | - | - | - | - | - | - |
Nettogewinn/-verlust | - | - | - | - | - | - | - | - |
▸ Netto-Marge | -% | -% | -% | -% | -% | -% | -% | -% |